JOSACINE 1000 mg, dispersible tablet 10 tablets
Active ingredients: Josamycin propionate, Josamycin
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JOSACINE 1000 mg, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- ASTELLAS PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60212424CIP73394117CIP133400933941178Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| JOSAMYCINE (PROPIONATE DE)comprimé | — | SA |
| JOSAMYCINE BASEcomprimé | 1000,00 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.